Valued at USD 23.70 billion in 2024, the opioid market is projected to reach USD 24.14 billion in 2025 and USD 28.45 billion by 2034, growing at a CAGR of 1.8% during the forecast period 2025–2034, according to Polaris Market Research. Formulation advances and a broadening product portfolio are shaping competition. Key players include Aurobindo Pharma Limited, Assertio Therapeutics, Inc.,...

The pain management landscape is undergoing a fundamental transformation driven by the opioid crisis and a growing understanding of chronic pain mechanisms. The Pain Management Market was valued at $75.23 billion in 2024 and is projected to reach $134.05 billion by 2035, exhibiting a CAGR of 5.39%. This growth is fueled by the accelerating shift from opioid-centric treatment paradigms...